Methyl gallate (Gallincin; NSC 363001), the methyl ester of gallic acid, is a plant phenolic with important biological activities such as antioxidant, anticancer, and anti-inflammatory propertes. Methyl gallate also shows antibacterial activity.
Physicochemical Properties
Molecular Formula | C8H8O5 |
Molecular Weight | 184.1461 |
Exact Mass | 184.037 |
CAS # | 99-24-1 |
PubChem CID | 7428 |
Appearance | White to off-white solid powder |
Density | 1.5±0.1 g/cm3 |
Boiling Point | 450.1±40.0 °C at 760 mmHg |
Melting Point | 201-204 °C |
Flash Point | 190.8±20.8 °C |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.631 |
LogP | 1.54 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Heavy Atom Count | 13 |
Complexity | 181 |
Defined Atom Stereocenter Count | 0 |
InChi Key | FBSFWRHWHYMIOG-UHFFFAOYSA-N |
InChi Code | InChI=1S/C8H8O5/c1-13-8(12)4-2-5(9)7(11)6(10)3-4/h2-3,9-11H,1H3 |
Chemical Name | InChI=1S/C8H8O5/c1-13-8(12)4-2-5(9)7(11)6(10)3-4/h2-3,9-11H,1H3 |
Synonyms | Gallincin; NSC 363001; NSC-363001; NSC363001; |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | HIV-1 |
ln Vitro | At a low dosage of methyl gallate (MIC=1 mg/mL), A. viscosus growth is totally inhibited. While Lactobacillus species are completely inhibited at a relatively high concentration (MIC=8 mg/mL), S. mutans and S. sobrinus exhibit intermediate sensitivity to methyl gallate (MIC=2-4 mg/mL)[1]. Cells exposed to a brief H2O2 treatment may experience less lipid peroxidation when methyl gallate is added at a concentration of 100 mM. Furthermore, cells treated with methyl gallate were able to stop intracellular glutathione (GSH) from being depleted after three hours of exposure to 8.0 mM H2O2[2]. Methyl gallate prevents effector CD4+ T cells from being suppressed by Treg cells and prevents Treg migration into the tumor environment. Furthermore, methyl gallate significantly reduces the expression of forkhead box P3 (Foxp3)[3]. |
References |
[1]. Inhibitory effect of methyl gallate and gallic acid on oral bacteria. J Microbiol. 2008 Dec;46(6):744-50. [2]. Protective effect of methyl gallate from Toona sinensis (Meliaceae) against hydrogen peroxide-induced oxidative stress and DNA damage in MDCK cells. Food Chem Toxicol. 2004 May;42(5):843-50. [3]. Methyl gallate exhibits potent antitumor activities by inhibiting tumor infiltration of CD4+CD25+ regulatory T cells. J Immunol. 2010 Dec 1;185(11):6698-705. [4]. First report on isolation of methyl gallate with antioxidant, anti-HIV-1 and HIV-1 enzyme inhibitory activities from a mushroom (Pholiota adiposa). Environ Toxicol Pharmacol. 2014 Mar;37(2):626-37. |
Additional Infomation |
Methyl 3,4,5-trihydroxybenzoate is a gallate ester obtained by the formal condensation of gallic acid with methanol. It exhibits anti-oxidant, anti-tumor, anti-microbial and anti-inflammatory properties. It has a role as a plant metabolite, an anti-inflammatory agent and an antioxidant. Methyl gallate has been reported in Camellia sinensis, Paeonia emodi, and other organisms with data available. See also: Paeonia lactiflora root (part of). |
Solubility Data
Solubility (In Vitro) | DMSO : 36~100 mg/mL ( 195.49~543.04 mM ) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (13.58 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (13.58 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (13.58 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 5.4304 mL | 27.1518 mL | 54.3036 mL | |
5 mM | 1.0861 mL | 5.4304 mL | 10.8607 mL | |
10 mM | 0.5430 mL | 2.7152 mL | 5.4304 mL |